Company
Aspeya Switzerland SA
Aspeya Switzerland SA has 1 drug tracked on RxWires: 1 in Phase 1.
Pipeline
| Drug | Phase | Indication |
|---|---|---|
| DHE inhalation powder low dose administered via dry powder inhaler (DPI) device | Phase 1 | Safety, and Tolerability |
Latest
No recent events.
Follow Aspeya Switzerland SA on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.